PER 4.65% 9.0¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-177

  1. 2,197 Posts.
    lightbulb Created with Sketch. 160
    I am not complaining that ANP is aiming dementia as next target, it is just too soon to talk about it as there is no proven evidences at the stage. step by step, I wish ANP could copy the the story for CUV, fingers crossed!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢
Change
0.004(4.65%)
Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.